Stock Insider Trading (from SEC Form 4)

MZJ / Merrill Lynch STEP Income Securities linked to Monsanto Co. due 8/17/2009 insiders include .


Merrill Lynch STEP Income Securities linked to Monsanto Co. due 8/17/2009 insider trades are found here. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.

Job titles are listed as of the filing and may not be current. Click the link icon to see the full transaction history.

Latest
File Date
Latest
Tran Date
Insider Code Shares Post Shares Percent
Change
Share
Price
Tran Value Post Value Percent
Change
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)

Related News Stories

The Bank of Nova Scotia's (RY) CEO Dave McKay on Q4 2017 Results - Earnings Call Transcript

2017-11-29 seekingalpha
Good morning, ladies and gentlemen. Welcome to the RBC 2017 Fourth Quarter Results Conference Call. I would now like to turn the meeting over to Mr. Dave Mun, SVP and Head of Investor Relations. Please go ahead, Mr. Mun. (40-0)

Top Analyst Upgrades and Downgrades: Bazaarvoice, GM, Home Depot, MGIC, Nike, T-Mobile and More

2017-11-28 247wallst
Stocks were indicated higher on Tuesday after a mixed session on Monday. The markets remain right at all-time highs, and the one trend that has won time after time is that investors have been rewarded every time they buy pullbacks. Those same investors are continuing to look for new investing and trading ideas to generate gains and income ahead. (99-1)

Insiders and Wall Street Heavyweights Jumping on 4 Battered Large Caps

2017-11-28 247wallst
Wall Street and investors can certainly be fickle friends when it comes to companies and where their money goes. Huge blue chip leaders can often turn into disasters when the fundamentals change, and often those fundamentals change because upper management doesn’t have the vision to change with the times. When bad times come, it sometimes takes a ton of money and, most importantly, courage to step up to the plate and buy. (88-0)

Bank Of America: Banking On A Brighter Future

2017-11-28 seekingalpha
Bank of America (BAC) looks to continue higher as its operations improve alongside an attractive valuation multiple. BAC is emerging from a long-term bottoming formation, with upside momentum on its side. BAC is positioned to benefit from an interest rates rise and an improving U.S. economy. Its valuation multiple also is lower than its peers, signaling it could outperform in coming years. (159-0)

UBS exits recruiting pact, following Morgan Stanley

2017-11-27 reuters
NEW YORK (Reuters) - UBS Group AG’s Wealth Management Americas said on Monday it was quitting a 13-year-old recruiting agreement that ended the practice of suing brokers who quit for jobs at competing firms, following a similar move by rival Morgan Stanley last month. (93-0)

UBS exits recruiting pact, following Morgan Stanley

2017-11-27 reuters
NEW YORK, Nov 27 (Reuters) - UBS Group AG’s Wealth Management Americas said on Monday it was quitting a 13-year-old recruiting agreement that ended the practice of suing brokers who quit for jobs at competing firms, following a similar move by rival Morgan Stanley last month. (93-0)

Biotech Forum Daily Digest: What Now For Recro Pharma?

2017-11-27 seekingalpha
The main biotech indices posted small gains in the holiday shortened trading week just before Thanksgiving. (332-0)

Merrill Lynch Has 4 Top Oil Stocks for 2018 With Oil at 2-Year Highs

2017-11-27 247wallst
West Texas Intermediate crude closed the day on Friday at $58.97 a barrel, which was the highest price in two years. Despite the dramatic 100% plus move off the lows posted in January of 2016, there is still a large swath of portfolio managers and analysts on Wall Street that remain either neutral or actually underweight the sector. With the potential for an OPEC continuation of the current production costs that are in place this week, it makes sense to look at adding some of the top stocks now. (81-1)

Top Analyst Upgrades and Downgrades: AECOM, Ciena, Evoqua Water Tech, Funko, GlaxoSmithKline, Square and Many More

2017-11-27 247wallst
Stocks were directionless on Monday, with most Americans slowly trickling back into the office after an extended Thanksgiving break. Still, the major U.S. indexes remain close to all-time highs and the trend that has won over and over is for investors to buy every pullback. Investors continue to look for new investing and trading ideas to generate gains and income ahead. (89-1)

2018 Comp: Merrill Lynch Adds Penalties/Awards to Spur Asset Growth

2017-11-26 advisorhub
Merrill Lynch on Wednesday put a dollar-and-cents handle on its concerns about the firm’s slothlike customer growth. (91-0)